Dihydromyricetin Inhibits Tumor Growth and Epithelial-Mesenchymal Transition through regulating miR-455-3p in Cholangiocarcinoma

Cholangiocarcinoma (CCA) leads to poor prognosis due to high aggressiveness and common chemoresistance. Dihydromyricetin (DMY), the main bioactive compound isolated from Ampelopsis grossedentata, exhibits broad anti-tumor effects. This study aimed to investigate the inhibitory effect of DMY on CCA t...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Xin, Yang, Zhou-Sheng, Cai, Wen-Wu, Deng, Yang, Chen, Lei, Tan, Sheng-Lan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2021
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8425191/
https://www.ncbi.nlm.nih.gov/pubmed/34539879
http://dx.doi.org/10.7150/jca.61311

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8425191/
https://www.ncbi.nlm.nih.gov/pubmed/34539879
http://dx.doi.org/10.7150/jca.61311

Ejemplares similares